Beauty Health (NASDAQ:SKIN – Free Report) had its target price reduced by Canaccord Genuity Group from $1.75 to $1.50 in a research report sent to investors on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a hold rating on the stock.
Beauty Health Stock Performance
NASDAQ:SKIN opened at $1.32 on Thursday. The firm’s 50-day moving average is $1.57 and its 200-day moving average is $1.57. Beauty Health has a 52-week low of $0.91 and a 52-week high of $4.62. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. The company has a market cap of $163.84 million, a price-to-earnings ratio of -3.14 and a beta of 0.84.
Beauty Health (NASDAQ:SKIN – Get Free Report) last posted its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.02. Beauty Health had a negative net margin of 8.11% and a negative return on equity of 44.83%. The company had revenue of $83.50 million for the quarter, compared to the consensus estimate of $78.02 million. During the same quarter in the previous year, the firm posted ($0.07) EPS. Equities research analysts anticipate that Beauty Health will post -0.25 earnings per share for the current year.
Institutional Trading of Beauty Health
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.
Further Reading
- Five stocks we like better than Beauty Health
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- What is the S&P/TSX Index?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How Technical Indicators Can Help You Find Oversold Stocks
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.